Skip to main content

Table 2 Hepatitis B antibody titers based on the rout of vaccination

From: Levamizole enhances immune responsiveness to intra-dermal and intra-muscular hepatitis B vaccination in chronic hemodialysis patients

HB vaccine groups positive seroconversion rate after 1 month (antibody titer/IU) positive seroconversion rate after 6 months (antibody titer/IU)
Group A (intra-muscular route by 40 microgram vaccine alone) 60% (28.9 ± 7) *P = 0.04 20% (16.7 ± 4)
Group B (intra-dermal route by 20 microgram vaccine alone) 70% (121.1 ± 82.3) #p = 0.005 60% (58 ± 7)
Group C (intra-muscular route by 20 microgram vaccine plus Levamisole) 90% (543.1 ± 494.4) §p = 0.008 80% (304 ± 7)
Group D (intra-dermal route by 20 microgram vaccine plus Levamisole) 90% (297.2 ± 90) €p = 0.6 80% (209 ± 46)
  1. Seroconversion rate percent (when Ab titer was more than10 IU/L) and HB antibody titers (IU/L) one month and six months after different routs of vaccination. *Denotes comparison of antibody titer between groups A and B.
  2. # Denotes comparison of antibody titer between groups B and D.
  3. §Denotes comparison of antibody titer between groups A and C.
  4. € Denotes comparison of antibody titer between groups C and D.
\